Bone Marrow TransplantationBone MarrowTransplantation, AutologousBone Marrow CellsUmbilical CordTransplantation, HomologousBone Marrow PurgingBone and BonesWhole-Body IrradiationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideHematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation ConditioningLeukemiaBone Marrow DiseasesLymphoma, Non-HodgkinCarmustineFetal BloodBusulfanAnemia, AplasticHematopoiesisGraft SurvivalColony-Forming Units AssayTransplantation ChimeraRemission InductionMelphalanLeukemia, Myeloid, AcuteTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsBone Marrow ExaminationRecurrenceBone RemodelingTime FactorsTissue DonorsCord Blood Stem Cell TransplantationBone Marrow NeoplasmsEtoposideHistocompatibility TestingLiver TransplantationHodgkin DiseaseLeukemia, MyeloidStem Cell TransplantationTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaCells, CulturedMice, Inbred C57BLT-LymphocytesCytarabineHistocompatibilityAntigens, CD34Umbilical VeinsCell DifferentiationFlow CytometrySurvival AnalysisRadiation ChimeraBone DensityUmbilical ArteriesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocyte CountAcute DiseaseActuarial AnalysisGranulocyte Colony-Stimulating FactorHematologic DiseasesCell SeparationHematologic NeoplasmsImmunosuppressive AgentsFollow-Up StudiesLymphomaHepatic Veno-Occlusive DiseaseMultiple MyelomaMyelodysplastic SyndromesLeukocytes, MononuclearKidney TransplantationBone ResorptionRetrospective StudiesImmunosuppressionGranulocytesSurvival RateBone TransplantationThiotepaBlood Cell CountDrug EvaluationImmunophenotypingVincristineDisease-Free SurvivalAntibodies, MonoclonalAntigens, CDGraft RejectionSalvage TherapyHematopoietic Stem Cell MobilizationPodophyllotoxinSpinal CordLymphocyte DepletionTransplantation ImmunologyGranulocyte-Macrophage Colony-Stimulating FactorBone NeoplasmsGraft vs Host ReactionPrognosis